Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis

Objectives. Determine the optimal, licensed, first-line anticoagulant for prevention of ischemic stroke in patients with non-valvular atrial fibrillation (AF) in England and Wales from the UK National Health Service (NHS) perspective and estimate value to decision making of further research. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Thom, Howard H. Z., Hollingworth, Will, Sofat, Reecha, Wang, Zhenru, Fang, Wei, Bodalia, Pritesh N., Bryden, Peter A., Davies, Philippa A., Caldwell, Deborah M., Dias, Sofia, Eaton, Diane, Higgins, Julian P. T., Hingorani, Aroon D., Lopez-Lopez, Jose A., Okoli, George N., Richards, Alison, Salisbury, Chris, Savović, Jelena, Stephens-Boal, Annya, Sterne, Jonathan A. C., Welton, Nicky J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699015/
https://www.ncbi.nlm.nih.gov/pubmed/31453363
http://dx.doi.org/10.1177/2381468319866828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699015/
https://www.ncbi.nlm.nih.gov/pubmed/31453363
http://dx.doi.org/10.1177/2381468319866828

Ejemplares similares